Tizaro Tirzepatide is a medication designed for managing type 2 diabetes and promoting weight loss. It functions as a dual-acting GLP-1 and GIP receptor agonist, enhancing insulin secretion and reducing appetite. Tizaro helps in controlling blood sugar levels while also aiding in significant weight reduction for patients
Mounjaro (tirzepatide) 12.5 mg is a treatment for type 2 diabetes, combining GIP and GLP-1 receptor agonist actions. It improves blood sugar control by increasing insulin secretion, lowering glucose production, and slowing gastric emptying. This dual-action approach helps manage blood sugar levels effectively in adults with type 2 diabetes.